| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825746 | Clinical Therapeutics | 2011 | 14 Pages |
Abstract
Low adherence inhibits the intensification of glucose-regulating but not antihypertensive medication in type 2 diabetic patients with insufficiently controlled risk factors in the Netherlands. Adherence problems may lead to diminished or even discontinued antihypertensive treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jaco PhD, Flora M. PhD, Bruce H.R. MD, PhD, Ronald P. MD, PhD, Petra PhD, Groningen Initiative to Analyze Type 2 Diabetes Treatment (GIANTT) Group Groningen Initiative to Analyze Type 2 Diabetes Treatment (GIANTT) Group,